The Colorado Dental Association (CDA) has chosen iCoreRx electronic prescribing software as its second iCoreConnect CDA Enterprises Endorsed Partner service.
Dentists must electronically prescribe schedule II, III, or IV controlled substances starting July 1, 2023, and iCoreRx is a good way for them to comply with the law, iCoreConnect said. The company is part of the StartUp Health accelerator. Its offerings -- iCoreRx, iCoreExchange, iCoreDental, and iCoreMD -- have been endorsed by more than 20 dental associations and medical societies across the U.S.
